Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

69.70
-2.8800-3.97%
Post-market: 69.700.00000.00%18:22 EDT
Volume:1.23M
Turnover:85.87M
Market Cap:13.51B
PE:-18.44
High:73.03
Open:72.33
Low:69.44
Close:72.58
52wk High:84.94
52wk Low:28.33
Shares:193.86M
Float Shares:151.20M
Volume Ratio:0.71
T/O Rate:0.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7800
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-33.83%
PB:-6.48
PE(LYR):-18.41

Loading ...

BridgeBio Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Dec 23, 2025

BridgeBio Oncology Therapeutics to Present at J.P. Morgan Healthcare Conference

Reuters
·
Dec 17, 2025

BridgeBio Pharma Is Maintained at Outperform by Leerink Partners

Dow Jones
·
Dec 16, 2025

BridgeBio Oncology Therapeutics Grants Stock Options Under New Inducement Plan

Reuters
·
Dec 12, 2025

Bernstein Initiates BridgeBio Pharma at Outperform With $94 Price Target

MT Newswires Live
·
Dec 11, 2025

BridgeBio Pharma Initiated at Outperform by Bernstein

Dow Jones
·
Dec 11, 2025

BridgeBio Pharma Inc : Bernstein Initiates Coverage With Outperform Rating; Target Price $94

THOMSON REUTERS
·
Dec 11, 2025

U.S. RESEARCH ROUNDUP-BioNTtech, GE Vernova, Synopsys

Reuters
·
Dec 11, 2025

BridgeBio Oncology Therapeutics Launches Phase 1 Trial of BBO-10203 in Advanced Solid Tumors

Reuters
·
Dec 11, 2025

BridgeBio Pharma Chief Accounting Officer Maricel Apuli Reports Sale of Common Shares

Reuters
·
Dec 10, 2025

BridgeBio Pharma CEO Neil Kumar Reports Disposal of Common Shares

Reuters
·
Dec 09, 2025

BridgeBio Pharma on Track for Record High Close -- Data Talk

Dow Jones
·
Dec 03, 2025

BridgeBio Pharma Management to Join Fireside Chats at Major Healthcare Investor Conferences

Reuters
·
Nov 25, 2025

BridgeBio Pharma CEO Neil Kumar Reports Disposal of Common Shares

Reuters
·
Nov 25, 2025

Jefferies Remains a Buy on BridgeBio Pharma (BBIO)

TIPRANKS
·
Nov 24, 2025

Does Acoramidis' Survival Benefit in V142I Cardiomyopathy Shift the Bull Case for BridgeBio Pharma (BBIO)?

Simply Wall St.
·
Nov 22, 2025

BRIEF-BridgeBio Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Nov 20, 2025

BridgeBio Pharma Grants Equity Awards to New Employees Under Amended 2019 Plan

Reuters
·
Nov 20, 2025

BridgeBio Pharma (BBIO) Receives a Buy from Jefferies

TIPRANKS
·
Nov 19, 2025

BridgeBio Pharma President and CFO Thomas Trimarchi Reports Disposal of Common Shares

Reuters
·
Nov 19, 2025